logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for global professionals · Monday, March 24, 2025 · 796,511,253 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Companies News  •••  Topics  •  Countries  •  U.S. States

Pfizer Profit News Monitoring

  • Published on Mar 19, 2025

    Pfizer offloads Haleon shares in $3.24 billion deal

    Pfizer has sold its entire stake in Haleon for approximately £2.5 billion ($3.24 billion), marking its complete exit from the consumer healthcare firm it helped create through a 2019 joint venture with GSK. The stake was offloaded at 385 pence per share to …

    Source: Profit by Pakistan Today - Neutral
  • Published on 04:44 GMT

    LETTER: A West Seattle neighbor's thoughts on eminent domain

    Dear Editor: 1) ST has a long history of not giving sufficient notice to owners of condemned properties. I could find news stories going back a long way, even before the one below. https://seattletransitblog.com/2017/09/29/sound- …

    Source: Westside Seattle - Washington State - Neutral
  • Published on Mar 23, 2025

    Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

    Valuation always matters in investing. And sometimes you can find stocks that are especially great bargains. Three Motley Fool contributors believe they've done just that. Here's why they think Altimmune (NASDAQ: ALT), Moderna (NASDAQ: MRNA), and …

    Source: Yahoo Finance - Label Pending
  • Published on Mar 22, 2025

    Here’s How the Right Is Packaging Its Conspiracies in Environmentalism

    Growing up in the early 2000s, my mother instilled within me certain precepts: eat your vegetables, avoid processed foods, recycle. Buying organic was preferable, but often cost-prohibitive. Ideally, you’d want to be able to pronounce the words on a label. …

    Source: Truthout - Left-wing
  • Published on Mar 22, 2025

    Iowa takes on Big Pharma: Bill challenges vaccine makers’ liability shield

    A subcommittee in the Iowa House of Representatives advanced House File 712, which would prohibit the sale and administration of vaccines in the state unless manufacturers waive certain liability protections granted under federal law. The bill specifically …

    Source: Natural News - Right-wing
  • Published on Mar 22, 2025

    Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Q4 2024 Earnings Call Transcript

    Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Q4 2024 Earnings Call Transcript March 20, 2025 Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.23, expectations were $-0.37. Operator: Greetings, and welcome to Monte Rosa …

    Source: Insider Monkey - Neutral
  • Published on Mar 21, 2025

    US-EU trade war could cost Ireland more than €18bn, says report

    A trade war between the US and the EU could cost Ireland more than €18bn, trigger waves of job losses and cause US multinationals to relocate, according to a report co-authored by the Irish government. Ireland’s GDP could shrink by 3.7% over the next five …

    Source: The Guardian - Center-left
  • Published on Mar 21, 2025

    Marjorie Taylor Greene Demands FDA Pull Approval of Dodgy COVID Vaccines ‘Causing Permanent Harm and Death’

    U.S. Congresswoman Marjorie Taylor Greene speaking with attendees at the 2021 AmericaFest at the Phoenix Convention Center in Phoenix, Arizona. (Credit: Gage Skidmore/Flickr) Congresswoman Marjorie Taylor Greene is demanding the Food and Drug …

    Source: The Gateway Pundit - Right-wing
  • Published on Mar 21, 2025

    AstraZeneca deepens China investment; Editas loses CFO to Dyne

    Today, a brief rundown of news involving AstraZeneca and Novartis, as well as updates from Editas, Adaptimmune and Pfizer that you may have missed. AstraZeneca will spend $2.5 billion over the next five years to set up a research and development center in …

    Source: BioPharma Dive - Label Pending
  • Published on Mar 21, 2025

    Alnylam drug gets long-awaited FDA approval in deadly heart disease

    The Food and Drug Administration on Thursday approved an Alnylam Pharmaceuticals medicine for a serious heart condition, a decision that should help the biotechnology firm secure its position as one of the sector’s most valuable companies. The agency …

    Source: BioPharma Dive - Label Pending
  • Published on Mar 21, 2025

    Alnylam prices heart drug at premium to rivals

    Alynlam Pharmaceuticals will sell its drug for a life-threatening heart disease at almost double the cost of other treatments available for the condition, company executives said Thursday. The price of the drug, Amvuttra, was revealed on a Thursday evening …

    Source: BioPharma Dive - Label Pending
  • Published on Mar 21, 2025

    Snowflake (SNOW) Price Prediction and Forecast 2025-2030 (March 2025)

    Forecasts Frame Stock Footage / Shutterstock.com Published: March 21, 2025 12:14 pm Last Updated: March 21, 2025 12:15 pm Shares of cloud-based storage solutions provider Snowflake Inc. (NYSE: SNOW) have endured a difficult month, falling -12.47% …

    Source: 24/7 Wall St. - Neutral
  • Published on Mar 21, 2025

    Alnylam enters the ATTR-CM drug race

    Morning! Today, we have plenty of interesting content from yesterday’s STAT Breakthrough Summit East in New York. Also, Alnylam wins an important approval for ATTR-CM.  Alnylam’s Amvuttra enters ATTR-CM drug race The FDA has approved Alynylam’s RNAi …

    Source: STAT - Massachusetts - Neutral
  • Published on Mar 21, 2025

    Alnylam joins three-way contest in ATTR cardiomyopathy

    Alnylam has the FDA approval it sought for Amvuttra in a form of cardiomyopathy associated with rare disease ATTR amyloidosis (ATTR-CM), allowing it to compete head-to-head with rival therapies from Pfizer and BridgeBio Pharma. Amvuttra (vutrisiran) has …

    Source: pharmaphorum - Neutral
  • Published on Mar 20, 2025

    Accenture stock falls 7% after Elon Musk’s DOGE cancels US contract with consulting giant

    Accenture warned Thursday that cost-cutting measures led by Elon Musk’s Department of Government Efficiency will hurt its bottom line because several multi-million dollar contracts were canceled — sending shares tumbling 7%. The consultancy giant’s CEO …

    Source: New York Post - Right-wing
  • Published on Mar 21, 2025

    Big pharma targets Australia. Could tariffs break the market?

    Join our daily newsletter At The Bell to receive exclusive market insights What if the cost of life-saving medicine in Australia skyrocketed overnight – all because of a trade war? That’s the risk as Big Pharma, led by U.S. giants like Pfizer, Johnson …

    Source: The Market Herald - Neutral
  • Published on Mar 21, 2025

    Lockdown+5

    It was only five years ago that neologisms like ‘self-quarantine’, ‘comorbidity’, ‘contact tracing’, ‘omicron’ entered the Nepali lexicon. PCR, CCMC, PPE, WFH and other acronyms were thrown about, and we became intimate with vaccine names: AstraZeneca, …

    Source: Nepali Times - Center-left
  • Published on Mar 21, 2025

    US FDA approves Alnylam's drug for rare heart condition

    (Reuters) -U.S. Food and Drug Administration approved Alnylam’s drug to treat a rare and deadly heart disease on Thursday, allowing the entry of a new type of medicine in a market dominated by Pfizer’s blockbuster Vyndaqel. The injectable drug, branded as …

    Source: WTVB - Michigan - Label Pending
  • Published on Mar 21, 2025

    US FDA expands approval for Alnylam’s drug to treat rare heart disease

    Audio By Carbonatix By Bhanvi Satija and Sneha S K (Reuters) -U.S. Food and Drug Administration approved Alnylam’s drug to treat a rare and deadly heart disease on Thursday, allowing the entry of a new type of medicine in a market dominated by Pfizer’s …

    Source: SRN News - Label Pending

  • 0
  • 0
  • 6
  • 6
days
  • 2
  • 2
  • 1
  • 1
hours
:
  • 3
  • 3
  • 2
  • 2
minutes
:
  • 3
  • 3
  • 9
  • 9
seconds

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
search news using your own keywords. There are 796,511,253 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Companies A-Z >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory >

Companies Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Companies Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Company News Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2025 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement